Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice

M. Berzosa, A. Nemeskalova, A. Zúñiga-Ripa, M. Salvador-Bescós, E. Larrañeta, RF. Donnelly, C. Gamazo, JM. Irache

. 2022 ; 14 (2) : . [pub] 20220120

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22010203

Grantová podpora
PI19/00146 Instituto de Salud Carlos III

Enterotoxigenic Escherichia coli (ETEC) infections have been identified as a major cause of acute diarrhoea in children in developing countries, associated with substantial morbidity and mortality rates. Additionally, ETEC remains the most common cause of acute diarrhea of international travellers to endemic areas. The heat-labile toxin (LT) is a major virulence factor of ETEC, with a significant correlation between the presence of antibodies against LT and protection in infected patients. In the present work, we constructed a recombinant LTB unit (rLTB) and studied the capacity of this toxoid incorporated in microneedles (rLTB-MN) to induce a specific immune response in mice. MN were prepared from aqueous blends of the polymer Gantrez AN® [poly (methyl vinyl ether-co-maleic anhydride)], which is not cytotoxic and has been shown to possess immunoadjuvant properties. The mechanical and dissolution properties of rLTB-MNs were evaluated in an in vitro Parafilm M® model and in mice and pig skin ex vivo models. The needle insertion ranged between 378 μm and 504 μm in Parafilm layers, and MNs fully dissolved within 15 min of application inside porcine skin. Moreover, female and male BALB/c mice were immunized through ear skin with one single dose of 5 μg·rLTB in MNs, eliciting significant fecal anti-LT IgA antibodies, higher in female than in male mice. Moreover, we observed an enhanced production of IL-17A by spleen cells in the immunized female mice, indicating a mucosal non-inflammatory and neutralizing mediated response. Further experiments will now be required to validate the protective capacity of this new rLTB-MN formulation against this deadly non-vaccine-preventable disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010203
003      
CZ-PrNML
005      
20220425131745.0
007      
ta
008      
220420s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics14020239 $2 doi
035    __
$a (PubMed)35213971
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Berzosa, Melibea $u Department of Microbiology and Parasitology, Institute of Tropical Health, IDISNA, University of Navarra, 31008 Pamplona, Spain
245    10
$a Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice / $c M. Berzosa, A. Nemeskalova, A. Zúñiga-Ripa, M. Salvador-Bescós, E. Larrañeta, RF. Donnelly, C. Gamazo, JM. Irache
520    9_
$a Enterotoxigenic Escherichia coli (ETEC) infections have been identified as a major cause of acute diarrhoea in children in developing countries, associated with substantial morbidity and mortality rates. Additionally, ETEC remains the most common cause of acute diarrhea of international travellers to endemic areas. The heat-labile toxin (LT) is a major virulence factor of ETEC, with a significant correlation between the presence of antibodies against LT and protection in infected patients. In the present work, we constructed a recombinant LTB unit (rLTB) and studied the capacity of this toxoid incorporated in microneedles (rLTB-MN) to induce a specific immune response in mice. MN were prepared from aqueous blends of the polymer Gantrez AN® [poly (methyl vinyl ether-co-maleic anhydride)], which is not cytotoxic and has been shown to possess immunoadjuvant properties. The mechanical and dissolution properties of rLTB-MNs were evaluated in an in vitro Parafilm M® model and in mice and pig skin ex vivo models. The needle insertion ranged between 378 μm and 504 μm in Parafilm layers, and MNs fully dissolved within 15 min of application inside porcine skin. Moreover, female and male BALB/c mice were immunized through ear skin with one single dose of 5 μg·rLTB in MNs, eliciting significant fecal anti-LT IgA antibodies, higher in female than in male mice. Moreover, we observed an enhanced production of IL-17A by spleen cells in the immunized female mice, indicating a mucosal non-inflammatory and neutralizing mediated response. Further experiments will now be required to validate the protective capacity of this new rLTB-MN formulation against this deadly non-vaccine-preventable disease.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nemeskalova, Alzbeta $u Department of Microbiology and Parasitology, Institute of Tropical Health, IDISNA, University of Navarra, 31008 Pamplona, Spain $u Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic
700    1_
$a Zúñiga-Ripa, Amaia $u Department of Microbiology and Parasitology, Institute of Tropical Health, IDISNA, University of Navarra, 31008 Pamplona, Spain $1 https://orcid.org/0000000178658994
700    1_
$a Salvador-Bescós, Miriam $u Department of Microbiology and Parasitology, Institute of Tropical Health, IDISNA, University of Navarra, 31008 Pamplona, Spain
700    1_
$a Larrañeta, Eneko $u Medical Biology Centre, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK $1 https://orcid.org/0000000337100438
700    1_
$a Donnelly, Ryan F $u Medical Biology Centre, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK $1 https://orcid.org/0000000207664147
700    1_
$a Gamazo, Carlos $u Department of Microbiology and Parasitology, Institute of Tropical Health, IDISNA, University of Navarra, 31008 Pamplona, Spain $1 https://orcid.org/0000000265864657
700    1_
$a Irache, Juan M $u Department of Pharmacy and Pharmaceutical Technology, University of Navarra, 31008 Pamplona, Spain $1 https://orcid.org/0000000196873436
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 14, č. 2 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35213971 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131743 $b ABA008
999    __
$a ind $b bmc $g 1784524 $s 1161401
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 2 $e 20220120 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
GRA    __
$a PI19/00146 $p Instituto de Salud Carlos III
LZP    __
$a Pubmed-20220420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace